Effects of phenobarbital treatment on serum thyroxine and thyroid-stimulating hormone concentrations in epileptic dogs

Journal of the American Veterinary Medical Association

Volumn 215, Issue 4, 1999, Pages 489-496

  Gaskill, Cynthia L ^a   Burton, Shelley A ^a   Gelens, Hans C J ^a   Ihle, Sherri L ^a   Miller, James B ^a   Shaw, Darcy H ^a   Brimacombe, Michael B ^a   Cribb, Alastair E ^a  

^a UNIVERSITY OF PRINCE EDWARD ISLAND   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCURONOSYLTRANSFERASE; PHENOBARBITAL; THYROTROPIN; THYROXINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOG; ENZYME ACTIVITY; EPILEPSY; HYPOTHYROIDISM; LIVER TOXICITY; NONHUMAN; PREVALENCE; REFERENCE VALUE; RISK FACTOR; SEIZURE; SPECIES DIFFERENTIATION; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; THYROXINE BLOOD LEVEL;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ANTICONVULSANTS; ASPARTATE AMINOTRANSFERASES; BILE ACIDS AND SALTS; CHOLESTEROL; CROSS-SECTIONAL STUDIES; DOG DISEASES; DOGS; EPILEPSY; FEMALE; GAMMA-GLUTAMYLTRANSFERASE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; IMMUNOENZYME TECHNIQUES; MALE; PHENOBARBITAL; SEIZURES; THYROID GLAND; THYROTROPIN; THYROXINE;

ANIMALIA; CANIS FAMILIARIS;

EID: 0033567001     PISSN: 00031488     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (55)

1. Schwartz-Porsche D, Loscher W, Frey HH. Therapeutic efficacy of phenobarbital and primidone in canine epilepsy: a comparison. J Vet Pharmacol Ther 1985;8:113-119.
2. Parent JM. Clinical management of canine seizures. Vet Clin North Am Small Anim Pract 1988;18:605-622.
3. Brown SA. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1988;18:1197-1216.
4. Frey HH. Anticonvnlsant drugs used in the treatment of epilepsy. Probl Vet Med 1989;1:558-577.
5. Podell M. Seizures in dogs. Vet Clin North Am Small Anim Pract 1996;26:779-809.
6. Boothe DM. Anticonvulsant therapy in small animals. Vet Clin North Am Small Anim Pract 1998;28:411-448.
7. Dayrell-Hart B, Steinberg SA, VanWinkle TJ, et al. Hepatotoxicity of phenobarbital in dogs: 18 cases (1985-1989). J Am Vet Med Assoc 1991;199:1060-1066.
8. Jacobs G, Calvert C, Kaufman A. Neutropenia and thrombocytopenia in three dogs treated with anticonvulsants. J Am Vet Med Assoc 1998;212:681-684.
9. Belshaw BE. Thyroid diseases. In: Ettinger SJ, ed. Textbook of veterinary internal medicine. 2nd ed. Philadelphia: WB Saunders Co, 1983;1592-1613.
10. Evinger JV, Nelson RW. The clinical pharmacology of thyroid hormones in the dog. J Am Vet Med Assoc 1984;185: 314-316.
11. Ferguson DC. Thyroid function tests in the dog. Vet Clin North Am Small Anim Pract 1984;14:783-808.
12. Podell M. Phenobarbital therapy: the good, the bad and the ugly, in Proceedings. 13th Annu Am Coll Vet Intern Med Forum 1995;435-438.
13. Feldman EC, Nelson RW Hypothyroidism. In, Feldman EC, Nelson RW, eds. Canine and feline endocrinology and reproduction. 2nd ed. Philadelphia: WB Saunders Co, 1996;68-111.
14. Yeo PPB, Bates D, Howe JG, et al. Anticonvulsants and thyroid function. Br Med J 1978;1:1581-1583.
15. Rootwelt K, Ganes T, Johannessen SI. Effect of carbamazepine, phenytoin and phenobarbitone on serum levels of thyroid hormones and thyrotropin in humans. Scand J Clin Lab Invest 1978;38:731-736.
16. Liewendahl K, Helenius T, Majuri H, et al. Effect of anticonvulsant and antidepressant drugs on iodothyronines in serum. Scand J Clin Lab Invest 1980;40:767-774.
17. Ilyes I, Tornai A, Kirilina S, et al. Influence of anticonvulsant drugs on thyroid hormones in epileptic children. Acta Paediatr Hung 1985;26:307-310.
18. Tanaka K, Kodama S, Yokoyama S, et al. Thyroid function in children with long-term anticonvulsant treatment. Pediatr Neurosci 1987;13:90-94.
19. Gomez JM, Cardesin R, Virgili N, et al. Estudio de los parametros de funcion tiroidea y de la TSH en pacientes tratados con farmacos anticonvulsionsantes. An Med Interna 1989;6:235-238.
20. Deda G, Akinci A, Tezic T, et al. Effects of anticonvulsant drugs on thyroid hormones in epileptic children. Turk J Pediatr 1992;34:239-244.
21. Yuksel A, Kartal A, Cenani A, et al. Serum thyroid hormones and pituitary response to thyrotropin-releasing hormone in epileptic children receiving anti-epileptic medication. Acta Paediatr Jpn 1993;35:108-112.
22. Verma NP, Haidukewych D. Differential but infrequent alterations of hepatic enzyme levels and thyroid hormone levels by anticonvulsant drugs. Arch Neurol 1994;51:381-384.
23. Kimura M, Yoshino K, Suzuki N, et al. Effect of antiepileptic drugs on thyroid function. Psychiatry Clin Neurosci 1995;49:227-229.
24. Kodama S, Tanaka K, Konishi H, et al. Supplementary thyroxine therapy in patients with hypothyroidism induced by long-term anticonvulsant therapy. Acta Paediatr Jpn 1989;31: 555-562.
25. Tiihonen M, Liewendahl K, Waltimo O, et al. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: a placebo-controlled thyroxine therapy trial. Epilepsia 1995;36:1118-1125.
26. McClain RM, Levin AA, Posch R, et al. The effect of phenobarbital on the metabolism and excretion of thyroxine in rats. Toxicol Appl Pharmacol 1989;99:216-228.
27. Curran PG, DeGroot LJ. The effect of hepatic enzyme-inducing drugs on thyroid hormones and the thyroid gland. Endocrinol Rev 1991;12:135-150.
28. De Sandro V, Chevrier M, Boddaert A, et al. Comparison of the effects of propylthiouracil, amiodarone, diphenylhydantoin, phenobarbital, and 3-methylcholanthrene on hepatic and renal T4 metabolism and thyroid gland function in rats. Toxicol Appl Pharmacol 1991;111:263-278.
29. Barter RA, Klaassen CD. Reduction of thyroid hormone levels and alteration of thyroid function by four representative UDP-glucuronosyltransferase inducers in rats. Toxicol Appl Pharmacol 1994;128:9-17.
30. Liu J, Liu Y, Barter RA, et al. Alteration of thyroid homeostasis by UDP-glucuronosyltransferase inducers in rats: a dose-response study. J Pharmacol Exp Ther 1995;273:977-985.
31. Chastain CB, Panciera DL. Hypothyroid diseases. In: Ettinger SJ, Feldman EC, eds. Textbook of veterinary internal medicine. 4th ed. Philadelphia: WB Saunders Co, 1995;1487-1501.
32. Ferguson DC. The dog as a model of thyroid physiology, in Proceedings. 16th Annu Am Coll Vet Intern Med Forum 1998;565-568.
33. Horney B, MacKenzie A, Burton S, et al. Evaluation of an automated, homogeneous enzyme immunoassay method for serum thyroxine measurement in the dog and cat. Vet Clin Pathol 1999;28:20-28.
34. Williams DA, Scott-Moncrieff JC, Bruner J, et al. Validation of an immunoassay for canine thyroid-stimulating hormone and changes in serum concentration following induction of hypothyroidism in dogs. J Am Vet Med Assoc 1996;209:1730-1732.
35. Boothe DM, Simpson G, Foster T. Effects of serum separation tubes on serum benzodiazepine and phenobarbital concentrations in clinically normal and epileptic dogs. Am J Vet Res 1996;57:1299-1303.
36. Quin JD, Thomson JA, Adverse effects of drugs on the thyroid gland. Adverse Drug React Toxicol Rev 1994;13:43-50.
37. Kaptein EM, Hays MT, Ferguson DC. Thyroid hormone metabolism: a comparative evaluation. Vet Clin North Am Small Anim Pract 1994;24:431-463.
38. Farwell AP, Braverman LE. Thyroid and antithyroid drugs. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman and Gilman's the pharmacological basis of therapeutics. 9th ed. New York: McGraw-Hill Book Co, 1996;1383-1397.
39. Lim CF, Bai Y, Topliss DJ, et al. Drug and fatty acid effects on serum thyroid hormone binding. J Clin Endocrinol Metab 1988;67:682-688.
40. Davies PH, Franklyn JA. The effects of drugs on tests of thyroid function. Eur J Clin Pharmacol 1991;40:439-451.
41. Capen CC. Mechanisms of chemical injury of thyroid gland. Prog Clin Biol Res 1994;387:173-191.
42. Merchant SR, Taboada J. Endocrinopathies. Thyroid and adrenal disorders. Vet Clin North Am Small Anim Pract 1997;27: 1285-1303.
43. Cavalieri RR, Pitt-Rivers R. The effects of drugs on the distribution and metabolism of thyroid hormones. Pharmacol Rev 1981;33:55-74.
44. Ferguson DC. Effect of nonthyroidal factors on thyroid function tests in the dog, in Proceedings. 7th Annu Am Coll Vet Intern Med Forum 1989;930-933.
45. Reimers TJ, Lawler DF, Sutaria PM, et al. Effects of age, sex, and body size on serum concentrations of thyroid and adrenocorti-cal hormones in dogs. Am J Vet Res 1990;51:454-457.
46. Gonzalez E, Quadri SK. Effects of aging on the pituitary-thyroid axis in the dog. Exp Gerontol 1988;23:151-160.
47. Minten J, Kuhn E, DeGeest H. Plasma concentrations of thyroid hormones in dogs: influence of sampling hour, breed and age. Chronobiol Int 1985;2:121-129.
48. Miller AB, Nelson RW, Scott-Moncrieff JC, et al. Serial thyroid hormone concentrations in healthy euthyroid dogs, dogs with hypothyroidism, and euthyroid dogs with atopic dermatitis. Br Vet J 1992;148:451-458.
49. Behrend EN, Kemppainen RJ, Young DW. Effect of storage conditions on cortisol, total thyroxine, and free thyroxine concentrations in serum and plasma of dogs. J Am Vet Med Assoc 1998; 212:1564-1568.
50. Ferguson DC. Update on diagnosis of canine hypothyroidism. Vet Clin North Am Small Anim Pract 1994;24:515-539.
51. Panciera DL. Hypothyroidism in dogs: 66 cases (1987-1992). J Am Vet Med Assoc 1994;204:761-766.
52. Peterson ME, Melian C, Nichols R. Measurement of serum total thyroxine, triiodothyronine, free thyroxine, and thyrotropin concentrations for diagnosis of hypothyroidism in dogs. J Am Vet Med Assoc 1997;211:1396-1402.
53. Scott-Moncrieff JC, Nelson RW, Bruner JM, et al. Comparison of serum concentrations of thyroid-stimulating hormone in healthy dogs, hypothyroid dogs, and euthyroid dogs with concurrent disease. J Am Vet Med Assoc 1998;212:387-391.
54. Jensen AL, Iversen L, Hoier R, et al. Evaluation of an immunoradiometric assay for thyrotropin in serum and plasma samples of dogs with primary hypothyroidism. J Comp Pathol 1996; 114:339-346.
55. Ramsey IK, Evans H, Herrtage ME. Thyroid-stimulating hormone and total thyroxine concentrations in euthyroid, sick euthyroid and hypothyroid dogs. J Small Anim Pract 1997;38:540-545.